Bioabsorbable Stents Market Size, Share, And Growth Report 2032

Bioabsorbable Stents Market Size

The global Bioabsorbable Stents market size was worth around USD 399.08 million in 2023 and is predicted to grow to around USD 698.66 million by 2032 with a compound annual growth rate (CAGR) of roughly 6.42% between 2024 and 2032.

The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD million). The report covers a forecast and an analysis of the Bioabsorbable Stents market on a global and regional level.

Request Free Sample

Bioabsorbable Stents Market: Overview

The stent is a polymer or metallic tube which is implanted in the lumen of a blood vessel to keep its passage open. A bioabsorbable stent is a special type of stent that reabsorbs or dissolves within the patient body. These stents are mostly used in the treatment of abnormalities related to the heart like blocked blood vessels. Besides, these are also implanted in the esophagus to allow the passage of food in patients suffering from esophageal cancer. They are also inserted in the gall bladder to allow the passage of bile, especially in patients suffering from gall bladder cancer, and in the ureter to prevent obstruction of urine flow from the kidney.

Besides, lack of necessary physical activity and unhealthy eating habits are leading to the development of cardiovascular diseases and increased need for percutaneous coronary interventions. Moreover, the disappearance of these stents from the treatment site adds several advantages like reduction in late-stent thrombosis, and facilitation of repeat treatments. Especially in pediatric surgeries, bioabsorbable stents do not require surgical removal and also facilitate vessel growth thus further boosting the market growth. But, the high cost associated with implant procedures, and stringent government regulations for stent approval are some of the factors hindering the market growth.

The study also includes drivers and restraints for the bioabsorbable stents along with the impact they have on the demand over the forecast period. Besides, the report includes the study of opportunities and trends available in the bioabsorbable stents market on a global level. The growing geriatric population base which is more vulnerable to strokes requires stent implants for treatment, rising adoption rate of these devices, technological advancements, and the risk of restenosis in patients undergoing angioplasty are some of the factors boosting the market growth of bioabsorbable stents market.

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. Macro-economic indicators such as healthcare industry outlook, healthcare spending, research funding, GDP along with company websites, company annual reports, white papers, financial reports, and other sources have also been considered to arrive at the indicated market numbers.

Request Free SampleBioabsorbable Stents Market: Segmentation

The study provides a decisive view of the bioabsorbable stents market by segmenting the market based on material, absorption rate, application, end user, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

Based on material the market is bifurcated into metallic stents and polymer-based stents. The polymer based stent segment held the major share of the market in 2023 and is likely to grow at a high CAGR in the forecast period since companies in this market are mainly focusing on the development of polymeric stents and due to the rising approvals for polymer-based stents in various countries.

Based on absorption rate the market is divided into slow- absorption stents, and fast- absorption stents. The fast- absorption stents segment is likely to grow at a high CAGR in the forecast period.

Based on application the market is segmented into peripheral artery diseases and coronary artery diseases. The coronary artery diseases segment held the major share of the market in 2023 due to the rising aging population which is more likely to be prone to coronary and due to the adoption of unhealthy lifestyle habits which has led to an increased risk of coronary artery diseases.

Based on the end user the market is segmented into cardiac centers, hospitals, and others. The hospitals' segment held the major share of the market and is likely to grow at a high CAGR in the forecast period due to the growing risk of PAD and CAD, the rising need for surgeries, and improving reimbursement scenarios in the hospitals.

Bioabsorbable Stents Market: Report Scope

Bioabsorbable Stents Market: Regional Analysis

Regional segmentation includes the current and forecast demand for the Asia Pacific, North America, Latin America, Europe, and Middle East & Africa with its further bifurcation into major countries. Europe and North America held major share of the market due to growing geriatric population base and increased awareness about treatment of coronary ailments. Besides, as per Epidemiological projections, approx. 25 Mn people in these regions suffer from peripheral artery disease.

Bioabsorbable Stents Market: Competitive Players

The report also provides a company market share analysis in order to give a broader view of the key players in the market. Industry insights and information is delivered in the required format. ZMR develops a list of industry players (manufacturers), distributors, retailers, and industry experts.

Some of the leading players in the global market include

• Medtronic Plc
• Abbott Laboratories
• Biotronik SE & Co. KG
• STENTYS SA
• Microport Scientific Corporation
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Terumo Corporation
• Elixir Medical Corporation
• C.R. Bard Inc.

The Global Bioabsorbable Stents Market is segmented as follows:

By Material Segment Analysis

• Polymer Based Stents     
• Metallic Stents

By Absorption Rate Segment Analysis

• Slow- Absorption Stents
• Fast- Absorption Stents

By Application Segment Analysis

• Coronary Artery Diseases
• Peripheral Artery Diseases

By End User Segment Analysis

• Hospitals
• Cardiac Centers
• Others

By Regional Segment Analysis

• North America

  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa